Knowledge Hub

API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019

Press Release   •   Nov 28, 2016 05:30 EST

MarketResearchReports.biz has recently announced the addition of a market study “ Active Pharmaceutical Ingredients (API) Market in India 2015-2019”, is a comparative analysis of the global market.

About Active Pharmaceutical Ingredients

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.

TechNavio's analysts forecast the API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the API market in India during the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process and area of therapy.

In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the API Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Vendors

Aurobindo Pharma

Cipla

Dr. Reddy's Laboratories

Other Prominent Vendors

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/879301

Anuh Pharma

Alembic Pharmaceuticals

A. R. Life Sciences

Atul Bioscience

Biocon

Cadila Pharmaceuticals

Calyx Chemicals & Pharmaceuticals

CIRON Drugs and Pharmaceuticals

CTX Life Sciences

Dishman Pharmaceuticals & Chemicals

Elder Pharmaceuticals

Emcure Pharmaceuticals

FDC

Glenmark Pharmaceuticals

Hetero Drugs

Hikal

Ind-Swift Laboratories

Ipca Laboratories

J. B. Chemicals and Pharmaceuticals

Laurus Labs

Lupin

Mangalam Drugs & Organics

Mylan Laboratories

Orchid Chemicals and Pharmaceuticals

Ranbaxy Laboratories

Sandoz

Sequent Scientific

Shasun Pharmaceuticals

Sterling Biotech

Sun Pharmaceutical Industries

The Piramal Group

Torrent Pharmaceuticals

Unichem Laboratories

Wockhardt

Market Driver

Strong Preference for Generic Drugs

For a full, detailed list, view our report

Market Challenge

Regulatory Ban

For a full, detailed list, view our report

Market Trend

Emergence of Africa

For a full, detailed list, view our report

Key Questions Answered in this Report

What will the market size be in 2019 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Table Of Content

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

07. API Market in India

07.1 Market Size and Forecast

07.2 Export and Domestic Consumption

07.3 Five Forces Analysis

08. Market Segmentation by Type of Production Process

09. Market Segmentation by Area of Therapy

09.1 API Market in India for Anti-infectives

09.1.1 Market Segmentation by Type

09.2 API Market in India for the Cardiovascular and Hematopoietic System

09.2.1 Market Segmentation by Type

09.3 API Market in India for the Central Nervous System

09.3.1 Market Segmentation by Type

09.4 API Market in India for the Gastro-intestinal and Hepatobiliary System

09.4.1 Market Segmentation by Type

09.5 API Market in India for the Respiratory System

09.5.1 Market Segmentation by Type

09.6 API Market in India for Oncology

09.6.1 Market Segmentation by Type

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges